Target intelligence / Profile preview

Cytoplasmic polyadenylation element-binding protein 4 (CPEB4)

Target
CPEB4
Molecular classification
RNA-binding protein, Translational regulator, Prion-like protein (family feature)
01

Overview

Cytoplasmic polyadenylation element-binding protein 4 (CPEB4) is a member of the CPEB family of RNA-binding proteins that regulate the cytoplasmic polyadenylation and subsequent translation of mRNAs through binding to specific cytoplasmic polyadenylation elements (CPE) in the 3' untranslated regions of target transcripts. CPEB4 contains two RNA recognition motifs and a zinc finger domain, enabling it to interact with select RNA sequences typically dependent on secondary RNA structure. CPEB4 is expressed in the cytoplasm and nucleus and is involved in key processes such as neuronal development and plasticity, cell differentiation, cell cycle control, and cellular stress responses including response to glucose deprivation and ischemia. Altered expression of CPEB4 has been linked to cancers (e.g., glioblastoma, hepatocellular carcinoma) and to chronic liver diseases where it can serve as a biomarker. CPEB4 does not currently have direct interacting drugs or established specific safety concerns as a therapeutic target based on available information.

Other names
KIAA1673CPE-BP4CPE-binding protein 4hCPEB-4
02

Biological functions

Regulation of polyadenylation and mRNA translationCell differentiationCell cycle progressionNeuronal synaptic plasticityCellular response to glucose starvationResponse to ischemia
03

Disease associations

Cancer (including glioblastoma and liver cancer)Liver cirrhosisPortal hypertensionPrimary biliary cholangitisNeurological/neurodegenerative diseases (implicated via family function, not specific to CPEB4)
04

Biomarkers

Liver cirrhosisPortal hypertensionPrimary biliary cholangitis

Beyond the preview

Go deeper on Cytoplasmic polyadenylation element-binding protein 4 (CPEB4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytoplasmic polyadenylation element-binding protein 4 (CPEB4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call